"Know Your Cataract EYE-Q" campaign launched to educate consumers about cataracts and their treatment. Read More »

Licensing agreement gives Grünenthal GmbH exclusive rights in Europe and Latin America. Read More »

FDA approves injectable gel to plump lips and reduce lines around the lips. Read More »

The Pharmacy Podcast Show recently marked a milestone - its 300th episode. Read More »

The American Pharmacists Association's (APhA) annual awards and honors program is set for March 24-27, 2017, and award nominations are being accepted now. Read More »

The CIO interactive community recognized CVS Health for excellence and leadership in IT. Read More »

The clinical trial evaluating patritumab as a treatment in non-small cell lung cancer will not proceed to the second part. Read More »

Kalia partners with Benzer Pharmacy to establish franchise in Tampa, Florida. Read More »

Upgraded website, plain language disclosures and frequent updates will help health care providers make informed decisions when purchasing health IT. Read More »

Liver disease therapy Ocaliva granted accelerated approval by FDA. Read More »

IUDs and oral contraceptives donated to help prevent pregnancy in areas affected by the zika virus. Read More »

CVS Pharmacy becomes the exclusive drugstore for the "Partner in Healthy Living" initiative. Read More »

First branded IV antibiotic approved for use with children in more than 10 years. Read More »

Zinbryta approved to treat relapsing forms of MS; only one monthly injection required. Read More »

Initial five stops on the tour announced; second consecutive summer tour to train pharmacists in point-of-care testing. Read More »

The interactive forum brings independent pharmacists together to collaborate on ways to expand business, improve profits and help their patients. Read More »

Webinar compliments NACDS efforts in Puerto Rico to encourage women to discuss the zika virus with their health care providers and pharmacists. Read More »

Expanded exclusion lists also could impact pharmacies, patients. Read More »

Sanofi announced this week that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the Food and Drug Administration (FDA) has recommended the approval of a new drug application from the company. Read More »

The Committee for Medicinal Products for Human Use (CHMP) within the European Medicines Agency has recommended the approval of saxa/dapa for use in treating type-2 diabetes. Read More »